DBV Technologies (DBVT) Retained Earnings (2019 - 2026)
DBV Technologies (DBVT) posted Retained Earnings of $408.3 million for Q2 2026, down 34.73% sequentially from $625.6 million in Q1 2026, and up 4.28% YoY from $391.5 million in Q2 2025.
DBV Technologies (DBVT) Retained Earnings (2019 - 2026) Analysis & Trends
DBV Technologies has reported Retained Earnings for 8 years, with the latest figure at $408.3 million in Q2 2026.
- Quarterly Retained Earnings rose 4.28% year-over-year to $408.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $408.3 million (up 4.28% YoY) and the FY2025 annual result came in at $541.3 million, up 71.51% from the prior year.
- Retained Earnings eased to $408.3 million in Q2 2026 per DBVT's latest filing, from $625.6 million in the prior quarter.
- Over five years, Retained Earnings peaked at $625.6 million in Q1 2026 and troughed at $314.5 million in Q2 2024.
- A 5-year average of $406.8 million and a median of $385.5 million in 2024 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2026: Retained Earnings tumbled 68.84% in 2022, then surged 97.16% in 2026.
- Over 5 years, Retained Earnings stood at $458.2 million in 2022, then decreased by 17.62% to $377.5 million in 2023, then retreated by 16.39% to $315.6 million in 2024, then soared by 71.51% to $541.3 million in 2025, then declined by 24.57% to $408.3 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered $408.3 million, $625.6 million, and $541.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | DBV Technologies | 6.08 Bn | 5.90 Bn | - | 408.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 408.30 Mn |
| Mar 31, 2026 | 625.60 Mn |
| Dec 31, 2025 | 541.30 Mn |
| Sep 30, 2025 | 392.06 Mn |
| Jun 30, 2025 | 391.55 Mn |
| Mar 31, 2025 | 317.31 Mn |
| Dec 31, 2024 | 315.61 Mn |
| Sep 30, 2024 | 316.10 Mn |
| Jun 30, 2024 | 314.51 Mn |
| Mar 31, 2024 | 379.43 Mn |
| Dec 31, 2023 | 377.47 Mn |
| Sep 30, 2023 | 376.25 Mn |
| Jun 30, 2023 | 375.76 Mn |
| Mar 31, 2023 | 459.85 Mn |
| Dec 31, 2022 | 458.22 Mn |
| Sep 30, 2022 | 456.88 Mn |
| Jun 30, 2022 | 456.45 Mn |
| Mar 31, 2022 | 359.48 Mn |
| Dec 31, 2021 | 358.12 Mn |
| Sep 30, 2021 | 359.08 Mn |